Our iron therapy products are available to healthcare professionals in the UK & Ireland only
More information at eMC or medicines.ie (SPC/PIL)
More information at eMC or medicines.ie (SPC/PIL)
More information at eMC or medicines.ie (SPC/PIL)
More information at eMC or medicines.ie (SPC/PIL)
If you experience a potential adverse event you should report it.
In the United Kingdom, reporting forms and information can be found at www.yellowcard.mhra.gov.uk
In Ireland, reporting forms and information can be found at www.hpra.ie
Adverse events should also be reported to Pharmacosmos E: pvuk@pharmacosmos.co.uk T: +44 1844 269 007
Patient safety always comes first, and by reporting a potential adverse event you help us maintain an up-to-date safety profile of our products
*Ferric derisomaltose Pharmacosmos 100mg/ml solution for injection/infusion is marketed as Monover® in Ireland
As a follow up to the information provided by the European commission in October 2013, we are pleased to share educational materials relating to the use of IV iron preparations.
Educational Materials for Patients (PDF)
Educational Materials for Healthcare Professionals (PDF)
